Between IMU and Celularity, they probably have enough cash to run a couple of quick phase one trials and straight into a registrational trial with onCARlytics and Celularity’s drug in combo. Might not be what’s happening but it’s what LC indicated could happen back when onCARlytics was acquired. We might find out when the 3 abstracts are published… and hopefully they’re in the process of submitting an FDA IND application.
Celularity Cap Raise...., page-13
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $400.5M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $320.3K | 5.830M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 3648610 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 164501 | 8 |
View Market Depth
| Last trade - 14.04pm 29/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |